Contact Us

Life Sciences

Integrated Project Management Company, Inc. (IPM) is an industry leader in life sciences Consulting.

IPM’s experience within the Life Sciences industry is broad and deep. For more than 30 years, we’ve managed thousands of projects for more than 150 biotech, pharmaceutical, and medical technology companies. Our clients range from startups to some of the world’s largest firms. We work onsite with your cross-functional experts to lead your critical projects and to ensure you meet your goals—efficiently, economically, and often ahead of schedule.

Our consultants, working individually or as a team, bring a wealth of industry experience, valuable leadership, and problem solving skills, and apply state of the art project management practices.  Our consultants have an average of 18 years’ experience and are Project Management Institute (PMP) certified. Most also hold advanced degrees (PhDs, MBAs, MS) and other certifications (Six Sigma, Lean, RAC).


Engage IPM For:

Hands on leadership of product development across the full product life cycle 

  • Research and development
  • Clinical development
  • Regulatory submissions
  • Commercial launch
  • Product lifecycle management
  • Pharmaceutical serialization

Create new or improve existing operational processes:

Responding to urgent corporate needs or organizational change

  • Managing timely and successful EU MDR implementation at every functional level
  • Assessing, diagnosing, and solving organizational/team problems
  • Mitigation of product quality regulatory problems, including recalls and remediations (e.g. 483 letters, Complete Response Letters)
  • Meeting the compliance timelines for serialization of the drug supply chain
  • Mergers and acquisitions, divestures
  • Changing the way your business operates

Contact us about your project.


“IPM provides more than just project management support; they share ownership for project deliverables and milestones. When I go to bed at night concerned about a project, I know the IPM project manager is worrying along with me.”

John Ludwig, Ph.D, Senior Vice President of Medicinal Sciences, Pfizer

“IPM has two attributes that differentiate them: the first is true commitment to client success; the second is their proactive approach to leveraging the collective talent of IPM. Their commitment to client success was exemplified by the time invested in getting to know not just my team but also our interfaces and stakeholders. When it comes to the breadth of IPM expertise, I was impressed by their rapid and effective engagement of experts from the Centers of Excellence, which facilitated delivery of solutions that met the breadth of our needs."

Vice President, Global Quality Analytical Science & Technology, who has engaged IPM at two top-tier biopharmaceutical companies

"IPM left an indelible mark. Our consultant left us with structures and processes in place that allow us to continue tracking and building our portfolio of projects and to communicate the value of our projects back to the rest of the organization."

Director, Product Management, Pharmaceutical Company


Featured Articles

Parallel Global Submissions: Navigating the Space Between Submission and Approval

Development of a novel therapeutic takes several years of intense research and detailed planning. Because target populations are likely to be distributed over multiple regions…

Read Article

Alphabet Soup: How GxPs Impact the Quality of a Regulatory Submission

If you are confused by the many acronyms related to regulatory submissions, you are not alone. A variety of data from disparate functions must come…

Read Article

10 Tips for Leading Successful Medical Device Development Projects

Overseeing the development of a new medical device is a challenging undertaking. There are many moving parts involved in the process and risks and pitfalls…

Read Article

New Drug Commercialization

A Project Leadership Perspective on Approaching Market Access A new drug product launch is an exciting time for a pharmaceutical company. New product development is…

Read Article

Painkiller: Smooth Acquisition Integration Critical to New Product Rollout for Pharma Company

A global multi-billion-dollar specialty pharmaceutical company was acquiring a smaller company with a pipeline of pain and spasticity drugs that would complement its own R&D…

Read Article

Regulatory Expertise Eases the Way for Company’s First IND Submission

A young biopharmaceutical company developing a pipe-line of preclinical cancer immunotherapy treatments was preparing to file its first investigational new drug (IND) application with the…

Read Article

Careful Planning Critical to Successful M&A Integration

When a global pharmaceutical and medical device company acquired another organization’s product portfolio, it faced the daunting task of integrating the new products into its…

Read Article

Optimized PPM Process Helps Medical Device Company Deliver Strategic Projects

The R&D team of a global medical device company was experiencing project slippage, diluted resources, prioritization problems, and too many projects within its current portfolio.…

Read Article

Pharma Company Beats the Competition with New Drug Marketing Program

When it comes to launching a new product, even companies with the most meticulously planned schedules can find themselves missing milestones while waiting—and waiting—for approval…

Read Article